| Filed On | Filing |
|---|---|
| 22 Sep 2026 |
Form 4: Gerber Hans-Peter, CHIEF SCIENTIFIC OFFICER
Received 3,750 shares by exercise or conversion · Gave up 1,345 shares to cover exercise price or tax ($20.6K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | 10-Q |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 30 Jul 2026 | SCHEDULE 13G |
| 09 Jun 2026 |
Form 4: Wigginton Jon Marc, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Petree Daniel H, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Panek James P, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Lobacki Joseph M, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Jagpal Sukhi, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Hunter Heidi, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Dybbs Michael, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Jun 2026 |
Form 4: Matsui Connie, Director
Granted 10,000 Stock Option (right to buy) |
| 08 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 02 Jun 2026 |
Form 4: Chow Gregory K., CFO
Received 2,500 shares by exercise or conversion |
| 15 May 2026 | SCHEDULE 13G |
| 15 May 2026 | SCHEDULE 13G/A |
| 14 May 2026 | 10-Q |
| 14 May 2026 | SCHEDULE 13G/A |
Loading...
